1 Followers
25 Following
chaitanyag11

chaitanyag11

Arm/Leg Rest Industry: Study Growth Factors with Market Forecasts 2026

Placing the weight of arms on armrest reduces downward gravity acting on the spine and helps in improving posture, maintaining the integrity of the spine and intervertebral discs. Leg rests have an adjustable angle, which are removable and have calf pads that support lower part of the leg when elevated. Such features of arm/leg rest are helpful in spinal cord injury patients.

 

Arm/Leg Rest Market – Drivers

Research and development activities in arm/leg rest technology for the comfort of users is expected to propel growth of the arm/leg rest market. For instance, in 2018, Soarigami, developed a new, portable, and user friendly armrest device. Its stainless steel hardware adjusts to different arm widths with removable coverings and durability and facilitates its use in airplanes, trains, stadiums, and other places.

 

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/2222

 

Arm/Leg Rest Market – Restraint

Difficulty in moving and height adjustment are reducing user compliance, which in turn is expected to restrain growth of the arm/leg rest market. For instance, according to report published by United Spinal Association, 2017, armrest contains movable parts, which tend to get damaged. Wheelchair armrests may also at times interfere with wheelchair propulsion, making wheels more difficult to move.

 

Arm/Leg Rest Market – Regional Analysis

On the basis of region, the arm/leg rest market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected hold a dominant position in the global arm/leg rest market over the forecast period. This is owing to increasing prevalence of spinal cord injuries, which further result in arm and legs disabilities. For instance, according to Spinal Cord.com statistics, 2017, around 17,500 new spinal cord injuries are registered in the U.S., annually.

Furthermore, Europe is expected to witness significant growth in the arm/leg rest market, owing to new product launches. For instance, in March 2016, Yanfeng Automotive Interiors (YFAI), a Germany-based company, developed a new heated armrest for door panels of cars. Such armrest offers comfort, flexibility, and energy efficiency during winter.

Key players operating in the arm/leg rest market include, Inmoclinc s.a, Provita medical gmbh & co. kg., KOHLAS, Bristol Maid, Medi-Plinth, Cardinal Health, General Electric Company, and Better Mobility Ltd.

 

Click To Reading More On Arm/Leg Rest Industry

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

Skull Clamp Market - Size, Share, Outlook, Global Insights

Skull Clamp Market – Restraint

Incidences of  injuries during usage of skull clamps is hampering the growth of skull clamp market. For instance, according to an article published in The Journal of the American Medical Association, (JAMA) 2016, skull clamp systems used in surgical procedures to immobilize the head and neck movement sometimes move or slip, leading to injuries such as skull fractures, facial cuts, and blood clots. This is hampering growth of the skull clamp market.

Skull Clamp Market – Regional Analysis

On the basis of region, the global skull clamp market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the skull clamp market, owing to increasing geriatric populations and increasing cases of brain injuries. For instance, according to a report published in The Morbidity and Mortality Weekly Report (MMWR) 2017, in the U.S., 153 people die due to traumatic brain injuries every day.

Get HOLISTIC Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2226

Asia Pacific is also expected to witness significant growth in the skull clamp market due to continuous foreign investments and less cost of spinal surgeries. For instance, according to data released by India Brand Equity Foundation on September 2018, healthcare has become one of India’s largest sectors both in terms of revenue and employment, and the cost of surgery in India is about one-tenth of that in the U.S. or Western Europe. Moreover, according to data released by the Department of Industrial Policy and Promotion (DIPP) 2018, the healthcare sector of India attracted Foreign Direct Investment (FDI) worth US$ 5.25 billion between April 2000 and June 2018.

Key players operating in the global skull clamp market include Allen Medical Systems, Inc., Barrfab, Eschmann Equipment, Medifa - Hesse GmbH & Co. KG, Schaerer Medical, TECHNOMED INDIA., OPT SURGISYSTEMS S.R.L., Micromar Ind. e Com. LTDA, pro med instruments, Inc., and Herbert.

Most neurosurgery procedures need rigid fixation of the head for successful operation. Skull clamps are indicated for such use in case of percutaneous craniotomies and spinal surgeries. They are placed on patient’s skull to hold their neck and head in proper posture during surgeries. Increasing number of neurosurgeries and development of new surgical techniques have led to demand for miniaturized instruments such as skull clamps to reduce post-surgical scars on body.

Skull Clamp Market – Drivers

Advancements in skull clamp technologies is expected to boost growth of the market. For instance, in October 2017, Mizuho OSI, a leading manufacturer of surgical equipment in the U.S., launched a new technology called Levo Head Positioning System at North American Spine Society (NASS), which will provide accurate head positioning during spine surgeries. It has various interchangeable modules, which supports efficient attachment to skull clamps providing safe and efficient patient care.

Click To Reading More On Skull Clamp Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Ostomy Care Market, by Device Type ,Opportunites,Growth,Trends And Global Insights

However, low awareness in underdeveloped and developing economies regarding the availability of treatments and increasing pricing pressure on the manufacturer is expected to confine the market growth.

Posterior Microsurgical Instruments Market – Regional Analysis,Trends, Outlook And Global Insights

Posterior Microsurgical Instruments Market – Driver

Organizing conferences and meetings by market players regarding posterior microsurgical are creating awareness amongst surgeons and patients, which is expected to drive growth of the market. For instance, Mercian Surgical Supply Co Ltd., company of U.K, is planning to exhibit a meeting for British Association of Spine Surgeons at Brighton, U.K., in April 2019, to discuss latest innovations in spinal surgeries.

Posterior Microsurgical Instruments Market – Restraint

The growth of global posterior microsurgical instruments market is depicted by the presence of various provincial and local vendors worldwide. This is creating huge competition for established players, as local vendors are providing such instruments at less cost, and thus hampering growth of the posterior microsurgical instruments market. Furthermore, according to a Sterilization and Infection Control Blog, October 2016, various surgical tools may remain inside the body post-surgery, causing harmful consequences among patients therefore, conducting further procedure become necessary, which in turn is expected to hamper growth of market.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2225

Posterior Microsurgical Instruments Market – Regional Analysis

On the basis of region, the global posterior microsurgical instruments market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America region is expected to dominate the global posterior microsurgical instruments market due to adoption of inorganic growth strategies by key players such as agreements in the U.S. For instance, in April 2017, 7D Surgical System, entered into exclusive sales representative agreements with two premier American medical device distributors, Surgical One and DB Surgical, for Machine-Vision Image Guided Surgery (MvIGS) technology. This new MvIGS platform can achieve fast surgical workflow for spine procedures.

Asia Pacific region is expected to witness significant growth in posterior microsurgical instruments market due to rapidly growing healthcare sector and less cost of surgeries. For instance, according to data published by India Brand Equity Foundation (IBEF), in September 2018, the cost of surgery in India is about one-tenth of that in the US or Western Europe and healthcare has become one of India’s largest sectors both in terms of revenue and employment.

Furthermore, According to report published by IBEF 2017, government announced to open three medical devices parks including, The 200 acre park being established in India. Such advancements in healthcare infrastructure will provide opportunities for adoption of various surgical tools including posterior microsurgical instruments, in turn propelling growth of the market.

Key players operating in posterior microsurgical instruments market include Volk Optical Inc., Ziemer Ophthalmic Systems, Novartis AG, Carl Zeiss Meditec AG, Lumenis, Abbott laboratories, Katalyst Surgical, LLC. Mercian Surgical Supply Co Ltd., and Rumex International Co.

Click To Reading More On Posterior Microsurgical Instruments Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

Posterior Microsurgical Instruments Market – Regional Analysis

The growth of global posterior microsurgical instruments market is depicted by the presence of various provincial and local vendors worldwide.

Tamoxifen Market: Regional Insights,Competitive Landscape,Opportunity Analysis 2026

Tamoxifen is a type of selective estrogen receptor modulator. The main pharmacologic action of Tamoxifen is to block the growth-promoting effects of estrogens on breast cancer. In bone cells, selective estrogen modulators interact with receptors the way estrogen does and strengthens bones. Tamoxifen is available in various forms such as powder, capsules, oral solution, and tablets.

Tamoxifen Market Dynamics

Being a generic molecule, the growth of the market has slowed down with increased competition. However, emergence of combination therapies and additional therapeutic indications for tamoxifen is expected to fuel the market growth. For instance, 2018 Novartis received breakthrough therapy designation for Kisqali by FDA in Phase 3. Designation was based on the successful phase 3 MONALEESA-7 trials, which demonstrated significant prolonged-free survival (PFS) of Kisqali + tamoxifen (or an aromatase inhibitor). Moreover, increasing number of government and non-government organizations are investing to discover additional therapeutic applications of tamoxifen, which in turn, is expected to boost market growth. For instance, In 2017 Duchenne UK, E-Rare, Duchenne Parent Project, and Monaco Association jointly contributed US$ 766,338 for a clinical trial, which aims to study the effects of tamoxifen in treating duchenne muscular dystrophy.

Tamoxifen Market – Competitive Landscape

Key players operating in the global tamoxifen market include Teva Pharmaceutical Industries Ltd, AstraZeneca plc, Aegis pharmaceuticals, Watson laboratories, Inc., Allergan plc, Mylan N.V., and Apotex Inc.Market players are focusing on adopting strategies such as acquisition and mergers to provide advanced research products to sustain their presence in the market. For instance, 2018 Dare Bioscience Inc. announced merger with Pear Tree Pharmaceuticals to procure rights to develop PT-101, as a potential treatment for vaginal and vulvar atrophy for patients suffering from hormone-receptive positive breast cancer. PT-101 is a proprietary vaginal formulation being developed by Pear Tree Pharmaceuticals.

Get PDF for more Professional and Technical insights@https://www.coherentmarketinsights.com/insight/request-sample/1801

Tamoxifen Market – Regional Insights

On the basis of region, the global tamoxifen market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America tamoxifen market holds the dominant position, owing to high acceptance and high price of the drug in treating breast cancer. For instance, according to GoodRx Inc. 2018 pricing detail, 30 tablets of tamoxifen 20mg cost around US$ 65.71 on an average. Moreover, increasing prevalence of breast cancer has propelled the tamoxifen market growth in the North America region. According to 2018, U.S. Breast Cancer Organization statistics, around 1 in 8 U.S. women are estimated to develop invasive breast cancer during the course of her life. Moreover, around 266,120 women are expected to be diagnosed with invasive breast cancer in the U.S. in 2018.

Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to its increasing number of people vulnerable to various chronic diseases and increasing healthcare initiatives. For instance, according to published article in the Lancet Oncology 2014, breast cancer is expected to rise from less than 60 cases per 100,000 woman aged 55-69 years to over 100 cases per 100,000 woman by 2021, reaching 2.5 million cases overall by 2021.

Tamoxifen is a type of selective estrogen receptor modulator (SERM) indicated for the treatment of women with high risk of breast cancer. Since its approval in 1998, tamoxifen has been used to treat millions of patients diagnosed with hormone receptor positive, early stage of breast cancer after surgery to reduce the risk of recurrence. It is the first choice for treatment of premenopausal women. Tamoxifen is the generic name for Nolvadex. Tamoxifen has off-label usage for the treatment of infertility, gynecomastia, retroperitoneal fibrosis, and idiopathic sclerosing mesenteritis.

 

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1801

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

Breathing Machines Market Regional Insights,Competitive Landscape,Market Dynamics

Breathing Machines Market Regional Insights

On the basis of region, the global breathing machines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global breathing machines market in terms of revenue share, owing to increasing number of patients receiving treatments for respiratory diseases. According to COPD International, in 2016, around 12 million people in the U.S. were suffering from COPD and an estimated 12 million more were undiagnosed. According to a Centers for Disease Control and Prevention (CDC) report, it is the fourth leading cause of death in the U.S.

 

Asia Pacific breathing machines market is expected to exhibit highest CAGR, owing to continuously increasing number of surgeries and respiratory disease burden in the region. For instance, according to WHO 2017 report, over 90% of COPD deaths occur in low­ and middle-income economies. The primary cause of COPD is exposure to tobacco smoke. Other risk factors include exposure to indoor and outdoor air pollution and occupational fumes and dusts.

 

Breathing Machines Market: Competitive Landscape

Key players operating in the global breathing machines market include BD, Drager Medical, Fisher & Paykel, GE Healthcare, Invacare, Maque, Medtronic, OMRON, Philips Healthcare, Teijin Pharma Resmed, and Weinmann. Key players are focusing on improving breathing machines by developing energy-efficient power systems and product features such as lightweight maneuverability, long-lasting components, and patient-friendly design.

 

Get The Holistic SAMPLE Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/2032

Breathing machine helps the patient to breathe while they are suffering from chronic respiratory diseases or unable to breathe by themselves after anesthesia. Breathing machines are used during surgeries that require general anesthesia, as the medicines used to induce anesthesia can disrupt normal breathing. The machine is required after the surgery, as the patient may not be able to breathe immediately after the procedure. The type of breathing machine used varies according to the problem.

 

Ventilators are mainly used in emergency medicine, home care, intensive care medicine, and in anesthesia, as a component of an anesthesia machine. The oxygen concentrator delivers pure oxygen via a mask or nasal cannula. It may be used in hyperbaric chambers and oxygen therapy. A C-PAP (continuous positive airway pressure) breathing machine blows air into the nose through a mask, which in turn keeps the airway open and helps in the absorption of oxygen.

 

Breathing Machines Market Dynamics

Increasing number of respiratory disorders such as asthma and COPD, and rising number of surgeries are expected to drive growth of the global breathing machines market. According to the National Institute of Health data of 2014, asthma affects over 24 million people in the U.S., including over 6 million children. Breathing problems can also occur due to serious conditions such as pneumonia, tuberculosis, lung cancer, and other lung diseases. According to the World Health Organization (WHO) estimates, by 2030, the four major potentially fatal respiratory diseases including COPD, pneumonia, lung cancer, and tuberculosis will account for around one in five deaths worldwide.

 

Millions of people in the U.S. suffer from breathing problems such as chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. COPD is a progressive life-threatening lung disease that causes breathlessness and predisposes to exacerbations and serious illness. In 2016, the Global Burden of Disease reported a prevalence of around 251 million cases of COPD worldwide. According to the same source, a total of 3.17 million deaths occurred due to COPD in 2015, which account for 5% of all deaths globally. COPD prevalence is expected to increase in the near future due to higher smoking prevalence and aging populations in many economies worldwide.

 

Click To Reading More On Breathing Machines Market

https://www.coherentmarketinsights.com/ongoing-insight/breathing-machines-market-2032

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

Gene Therapy Market Trend, Growth, Outlook,Major Key Players And Market Analysis 2025

Gene Therapy Market – Dynamics

Demand for gene therapy is significantly increasing due to increasing number of patients suffering from hereditary disorders, cancer, HIV, and various chronic diseases. For instance, 2018 American Cancer Society report showed cancer was responsible for 609,640 deaths in the U.S. Moreover, in 2017, WHO reported 1.0 million deaths were caused due to HIV-related illnesses worldwide. Increasing technological developments, innovations, and clinical and pre-clinical trials. For instance, According to published article in 2014 Regenerative Medicine reports 4749 registries of clinical trials related to stem cell treatment. Several diseases are likely to propel growth of the gene therapy market size during the forecast period. Moreover, increasing research and development funding by government agencies and commercial market players for the development of innovative, efficient, and safer gene therapy practices is boosted the market growth. For instance, 2017 National Institutes of Health was funded US$ 1,644 million for stem cell research. Furthermore, growing awareness and community acceptance of gene therapy for various disease treatments is propelling growth of the market.

However, unwanted immune responses related to treatment, concerns regarding unethical use of gene therapy and high cost associated with the treatment can hamper the market growth.

Get PDF for more Professional and Technical insights@

https://www.coherentmarketinsights.com/insight/request-sample/1774

Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with the help of gene therapy normal copy of that missing or faulty protein can be introduced to restore the function of the protein. All over the world, gene therapy is being extensively studied by the researchers for the treatment of various diseases such as HIV, Cancer, Parkinson’s disease, hemophilia and even immune deficiencies through various approaches. For instance, According to 2015, article published in Journal Gene Technology and Resistance to Viruses has shown the future prospect of the bone marrow gene therapy for HIV treatment. Three primary approaches being practiced in the gene therapy are substituting a mutated gene with the healthier one, disabling a mutated gene that is functionally inappropriate and introducing a novel gene in the body to fight a disease. In the gene therapy treatment, vectors are responsible for insertion of functional gene into the genome of an individual tissues and cells, one of the most common vectors are viruses. The gene therapy treatment which was once considered as unfeasible, has now become a trend among small and big companies. Result of this has been an increased the in the number of various successful startups, backed by financiers in line with giant companies these have boosted the growth of the market.

Gene Therapy Market – Competitive Advances

Key players operating in the global gene therapy market include GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck KGaA, Transgene SA, and OncoGenex Pharmaceuticals, Inc. These companies are conducting various clinical and pre-clinical developmental stages of gene therapies. Key players are engaged in developing new technologies and are focusing on collaborating with leading companies in order to retain their foothold in the global market. For instance, in 2017, the U.S. Food and Drug Administration (FDA) approved a gene therapy called Luxturna, developed by Spark Therapeuticsa Biotech Company based in Philadelphia.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1774

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

Poly Adenosine Diphosphate Ribose Polymerase Market By Drug Olaparib, Rucaparib, Niraparib By Region Latin America, Europe

Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. According to American Cancer Society (ASC), around 22,240 women are expected to be diagnosed with ovarian cancer, and around 14,070 deaths are expected from the disease in 2018.

Furthermore, introduction of new drugs has propelled the poly adenosine diphosphate ribose polymerase market growth. For instance, the U.S. Food & Drug Administration approved 3 PARP inhibitors—Olaparib, Rucaparib, and Niraparib. These drugs are a potential alternative that aid in treatment of ovarian and other cancers after paclitaxel.

Moreover, combination of these PARP inhibitors with other therapies such as monoclonal antibodies is under research. For instance, in May 2018, TESARO, Inc.—an oncology-focused biopharmaceutical company— announced collaboration with Genentech—a member of the Roche Group—to evaluate the combination of the PD-L1 antibody— Atezolizumab (TECENTRIQ), the MEK inhibitor cobimetinib (COTELLIC), and TESARO’s PARP inhibitor ZEJULA (Niraparib) — in patients with platinum-sensitive ovarian cancer. In April 6, 2018, the U.S. Food and Drug Administration (FDA) approved Rubraca (rucaparib) tablets --manufactured by Clovis Oncology Inc.—for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients.

Get PDF for more Professional and Technical insights@

https://www.coherentmarketinsights.com/insight/request-sample/2029

Poly Adenosine Diphosphate Ribose Polymerase Market Regional Insights

North America and Europe are expected to witness significant growth in the poly adenosine diphosphate ribose polymerase market over the forecast period. Increasing demand for approved drugs, owing to high prevalence of various types of cancer is expected to facilitate growth of the market, in the U.S. For instance, according to American Cancer Society (ASC), around 164,690 new cases are expected to be diagnosed with prostate cancer in 2018.

New product launches and robust pipeline of PARP inhibitors is expected to boost the North America, and Europe PARP inhibitors market growth over the forecast period. For instance, Clovis Oncology launched Rubraca (Rucaparib) in 2016, and Tesaro, Inc. launched Zejula (Niraparib) in 2017. Moreover, Lynparza (Olaparib) manufactured by AstraZeneca Plc was approved by the U.S. Food & Drug Administration for the treatment of germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer in January 2018.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2029

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website:https://www.coherentwire.com

Ureteral Stents Market - Regional Insights And Major Key Players Like Applied Medical

Ureteral stents are small tubes inserted into the ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder.

Ureteral Stents Market - Regional Insights And Major Key Players Like Applied Medical, Allium Medical, Bard Medical, B.Braun, Boston Scientific, Cook Medical

Ureteral stents are small tubes inserted into the ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder. Ureteral stents are flexible in nature and approximately 10 inches in length. The most common application of ureteral stents is the treatment of kidney stones. Other applications include stricture (abnormal narrowing of the ureter), and tumors pushing the ureter, leading to a blockage. Moreover, swollen, inflamed, or damaged ureteral tubes in need of healing can have a stent placed to keep the kidney draining during the healing process.

The global ureteral stents market size was valued at US$ 492.6 million in 2017 and is expected to witness a CAGR of 5.7% over the forecast period (2018 – 2026).

Get PDF for more Professional and Technical insights@

https://www.coherentmarketinsights.com/insight/request-sample/2172
Increasing prevalence kidney related disorders is expected to drive the ureteral stents market revenue

Rising prevalence of urolithiasis worldwide owing to changes in lifestyle such as lack of physical activity and dietary habits is the major factor driving the ureteral stents market revenue. Urolithiasis is a common urologic problem and constitutes a significant burden on the health care system. According to the National Health and Nutrition Examination Survey (NHANES) 2003 report, the prevalence of urolithiasis has increased over the last three decades in the U.S. and projected to experience economic burden, with an additional value of US $1.24 billion per year by 2030.

Along with elderly and adult population, kidney stones also affect children of all ages. According to the Journal of Urology 2015 data, ureteral stent placement is the most common procedures performed in approximately 20% of children with stones. The weighted average annual cost of care for pediatric urolithiasis is US $220 million per year.

Urinary incontinence (UI) is also a significant health problem worldwide with increasing geriatric population rate. It has a large economic and social impact on individuals and nation. According to the European Urology 2012 report, the Epidemiology of Lower Urinary Tract Symptoms (EpiLUTS) reported relatively high UI prevalence rates of 13.3% for men and 30.3% for women in the United Kingdom, Sweden, and the U.S.

Ureteral Stents Market - Regional Insights

On the basis of region, the global ureteral stents market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America and Europe are expected to foresee significant growth in 2026 owing to increased number of urological surgeries, increasing prevalence of kidney stones and presence of major industry players. According to a European Urology study of 2012, in the U.S., kidney stone affects 1 in 11 people, and it is estimated that approximately 600,000 Americans suffer from urinary stones every year.

Asia Pacific ureteral stents market is expected to grow at highest CAGR due to increasing obesity and diabetes patient population prone to kidney disorders and developing healthcare infrastructure in the region. According to a research study published in Current Science journal 2005 data, in India, nearly 12% of patient had urinary stones and out of which 50% may end up with loss of kidney functions.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2172

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website:https://www.coherentwire.com

Global Molecular Imaging Market Is Expected To Witness A CAGR Of 8.1% over The Forecast Period

Increasing incidence of cancer, cardiovascular, and neurological diseases are expected to drive the molecular imaging market growth

Increasing incidence of various diseases such as cardiovascular, cancer, inflammatory, and neurological diseases are propelling demand for molecular imaging and is expected to drive the molecular imaging market growth during the forecast period. These diseases are becoming increasingly prevalent with rising percentage of geriatric population worldwide. According to the American Heart Association 2015 data, in the U.S., around 2 million people die due to cancer and cardiovascular disease annually.

Medical imaging is used for the early diagnosis and management of these diseases.  For instance, for solid tumors, novel molecular imaging modalities such as Ultrasound, PET-CT, and MRI can facilitate earlier and more accurate diagnosis and staging, which are requisites for successful surgical therapy. Molecular imaging also plays an important role in dementia evaluation. According to the Society of Nuclear Medicine and Molecular Imaging, researchers are exploring the use of additional neuroimaging probes, including FDDNP and amyloid markers, to visualize abnormal plaques and tangles associated with Alzheimer’s disease.

Get PDF for more Professional and Technical insights@ https://www.coherentmarketinsights.com/insight/request-sample/2191

Molecular Imaging Market Restraints

However, there are some limitations associated with all molecular imaging modalities, which may restrain molecular imaging market growth. For instance, optical imaging lacks penetration depth, especially when working at visible wavelengths. Depth of penetration is used for the absorption and scattering of light to identify molecular structure. Moreover, optical imaging and ultrasound do not offer whole body imaging. MRI offers unlimited depth penetration and whole body imaging, however, it is more costly than other modalities. PET-CT imaging is not recommended for all patients due to harmful radiation that causes side effects to the body. For instance, it is not suitable for pregnant women, as the radiation could harm the baby.

Molecular Imaging Market - Regional Insights

On the basis of region, the global molecular imaging market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America molecular imaging market is expected to foresee major revenue share, owing to well established healthcare infrastructure that offers all the molecular imaging modalities in various parts of the region. Moreover, increasing awareness among people about health coupled with prevalence of various diseases including cardiovascular, cancer, brain disorders is propelling demand for molecular imaging in the region.

According to the Alzheimer’s Association, in 2017, over 5 million people were suffering from Alzheimer’s disease, which is also reported to be the sixth-leading cause of death in the U.S. According to Center for Disease Control (CDC), 2016, around 610,000 deaths were reported in the U.S. annually due to cardiac arrest and other cardiovascular diseases. This rate could be lowered with proper diagnostic and imaging technologies leading to opportunities for molecular imaging market growth.

Asia Pacific molecular imaging market is anticipated to grow at highest CAGR, owing to increasing healthcare funding from government and private organizations to develop technologically advanced medical systems to fulfil demand of increasing population suffering from various diseases. Moreover, trends such as an increasing aging population, urbanization and chronic diseases underpin the demand for improved diagnostic care in the region. According to International Association of Cancer Registries, in 2012, over 600,000 new breast cancer cases were reported in Asia, accounting for 39% of all breast cancers diagnosed worldwide.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2191

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website:https://www.coherentwire.com

Patient Engagement Solution Market- By End-use, By Application, And Segment Forecasts

Patient Engagement Solutions (PES) combines a patient’s knowledge, skills, ability, and willingness to manage own health with communications from health provider designed to promote positive behaviors. For instance, if patient is suffering from cardiovascular disease, patient engagement solution takes effort to remind patient about of why, when, how, and where they can get relevant care for CVD, which in turn allows patients to control disease and avoid adverse events.

The Affordable Care Act (ACA) further promotes the growth of this sector by introducing programs, such as the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS), at hospitals to conduct surveys that gather information with respect to patient satisfaction associated with hospital care and services. This serves as a tool for standardized measurement of the quality of care administered at hospitals.

The increased patient participation achieved through such patient engagement efforts would impact health outcomes and subsequently enhance the healthcare delivery of the present medical system. Technological advancement, access to big data and rise of consumerism in healthcare are the major factors which could drive the demand for patient engagement solutions in various organizations

Get The Holistic SAMPLE With Research Methodology:

https://www.coherentmarketinsights.com/insight/request-sample/2058

Patient Engagement Solution Market-Market Dynamics

Patient engagement solutions market is expected to witness upward growth during forecast period due to rising prevalence of chronic disease worldwide. Chronic disease such as cancer, cardiovascular disease, diabetes, asthma (chronic lung disease) results into significant deaths each year. According to World Health Organization data (WHO) in 2017, around 40 million people die annually due to chronic disease, which accounts for 70% of all deaths worldwide. Cardiovascular diseases are responsible for 17.7 million death annually, followed by cancers (8.8 million deaths), respiratory diseases (3.9million deaths), and diabetes (1.6 million deaths). Patient engagement solutions benefits the better clinical management of this disease by engaging patient about their health and in turn maintaining patient base for hospital or clinic.

Click To Reading More On Patient Engagement Solution Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website:https://www.coherentwire.com

Telehealth Market Koninklijke Philips N.V., Medtronic, Tunstall Healthcare Group, McKesson Corporation Includes Major Key Players

Increasing prevalence of chronic disease with rising healthcare expenditures and high adoption of health IT infrastructure to support telehealth initiatives are also expected to further boost growth of the telehealth market. Veterans Health Administration (VHA) - the largest integrated health care system in the U.S. uses multiple types of telehealth interventions, which provides both routine and targeted care management services. The 2017 finding from Centers for Medicare and Medicaid Services (CMS), stated that telehealth and telemedicine payments increased by 28% and claims increased by 33% in 2016, over the year 2015. However, lack of trained professionals in remote areas, privacy and information security concerns, and low availability of telecommunication bandwidth are the major factors adversely affecting growth of the telehealth market. 

Autoclave Market: Competitive landscape,Regional Insights

The factor attributed to growth of the autoclave market is rising number Hospital-Acquired Infections (HIA) along with occurrence of pathogens, bacterial, fungal & viral diseases worldwide. For instance, according to the Centers for Disease Control (CDC) analysis, around 99,000 people die every year due to the HIA infections, worldwide. Furthermore, according to the World Health Organization (WHO), an estimated 15% of all hospitalized patients suffer from these infections every year. Increasing the HIA infections during hospitalization is due to exposure of patients to pathogens through different sources environment, healthcare staff, and other infected patients. Therefore, autoclave plays an important role in controlling HIA infections in hospital, as this instruments is used for sterilizing surgical equipment, laboratory instruments, and pharmaceutical items. This in turn help in preventing growth of the bacteria, which inadvertently help in reducing the growth of the disease caused by infection spread from the medical instruments. Hence, this factor is expected to fuel growth of the autoclave market during the forecast period (2018 - 2026).

Get The Holistic SAMPLE Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/2124

Global Autoclave Market: Regional Insights

The market for autoclave in Asia Pacific region accounted for the largest market share in 2017, and expected to hold the largest market share over the forecast period (2018 - 2026).  Owing to increase in number of patients suffering from Hospital acquired Infection (HIA) is one of the major factors driving growth of the market in these particular region. For instance, the International Nosocomial Infection Control Consortium (INICC) assessed the rates of device associated infections across 40 Indian hospitals compared to a number of other countries. Therefore, in order to minimize the case related to HIA infection is inadvertently increase the demand of the autoclave in these particular region.

Furthermore, introduction of government state policy for controlling and preventing incidence related to the health acquired infection is another factor driving growth of the market. The state policy will be based on framework formulated by WHO, which is implemented to the government hospitals. For instance, in 2004, WHO introduced the national patient safety policy to address the patient safety related issues such as hand hygiene, antimicrobial resistance, and safe injections. Moreover, formation of India Patient Safety Organization (IPSO) will be a first organization in India, which will take the ownership and responsibility of educating the workers of healthcare regarding patient safety, which in turn help in reducing the disease caused by medical error. Hence, all these factor are expected to drive growth of the market in these particular region.

Global Autoclave Market: Competitive landscape

Key players operating in the global autoclave market include MELAG Medizintechnik oHG, Tuttnauer, Getinge AB, Belimed, SAKURA SEIKI Co., Ltd., Shinva Medical Instrument Co., LTD., Astell Scientific, STERIS plc. BMM Weston Ltd., LTE Scientific Ltd, Panasonic Biomedical Sales Europe B.V., Priorclave Ltd., Life Steriware, Accumax India, and Consolidated Sterilizer Systems.

The key players of the autoclave market adopted the product development strategy in order to gain the competitive edge in the market. For instance, in September 2017, Astell Scientific, the leading manufacturer and distributor of autoclaves, steam generators, and effluent decontamination systems launched a new and improved range of autoclaves. The new range of circular chamber autoclaves is available in various sizes, as benchtop, compact, and free-standing units, and with options of top and front loading configurations.

Click To Reading More On Autoclave Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website:https://www.coherentwire.com

Medical Ceramics Market Share And Top Companies CoorsTek Medical,H.C. Starck GmbH, Tosoh Corporation,Noritake,3M ESPE,Morgan

These are primarily used in dental and orthopedic applications, mainly as implants or replacements. For load-bearing hip prostheses, the ceramic used is of high-purity, high-density, and fine-grained polycrystalline alumina. Other bioceramic implants can also serve as porous media to support the ingrowth of new bone tissue such as materials that bioreact with bone, or as scaffolds that are completely resorbed after establishing a template for tissue growth. Rising cases of joint related diseases and dental problems have led to the introduction of new technologies and methods by medical device manufacturers and other intermediaries. In 2016, Glidewell Laboratories launched a new line of dental bone grafting products under the brand name Newport Biologics. This is expected to fuel adoption of medical ceramics over the forecast period.

 

The global medical ceramics market is estimated to be valued at US$ 3,835.7 million in 2017 and is expected to witness a CAGR of 6.1% over the forecast period (2017–2025).

 

Get The Holistic SAMPLE With Research Methodology:

https://www.coherentmarketinsights.com/insight/request-sample/1261

 

Rising number of medical procedures involving dental implants, orthopedic implants, and others is one of the major factors driving growth of this market. According to the European Commission, 2015, around 800,000 hip procedures were carried out every year in Europe, costing around US$ 1.5 billion. The market growth is also driven by development of novel product varieties with higher mechanical strengths and flexibility. Due to their excellent frictional properties, technical ceramics are gaining popularity in endo-prosthetics. Increasing trauma cases due to falls and road accidents, requires medical intervention (orthopedics), thus, augmenting the need for medical ceramics products. In 2012, according to the National Institute of Health, knee is the most commonly injured joint by adolescent athletes with an estimated 2.5 million sports-related injuries presenting to emergency departments, annually in the U.S. This number is expected to increase significantly over the forecast period.

 

Manufacturers are focusing on developing new ceramics to be used in various medical applications. For instance, in March 2017, CeramTec launched its newly developed dental ceramic, Zirconium Oxide Bright, at International Dental Show (IDS) in Cologne, Germany. The material combines high translucency and high strength and is suitable for all dental prostheses treatments.

North America market accounted for the largest market share, followed by Europe in 2016. This is owing to high usage of implantable medical devices, furthermore, rise in number of osteoporotic fractures in the U.S. and presence of relatively large number of medical device manufacturers in this region is expected to be a factor for growth of the medical ceramics market in this region. For instance, according to the National Osteoporosis Foundation (NOF), over 1.3 million osteoporotic fractures occur each year in the U.S. The market in Asia Pacific and Latin America is also expected to witness substantial growth. This is owing to rise in medical tourism for dental and orthopedic procedures. According to the study by Far International, 2016, the knee replacement surgery costs around US$ 40,000, whereas the costs in Colombia is only US$ 15,000.

Click To Reading More On Medical Ceramics Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com